4901 - 4910 of 8816 Results
Title
Year
-
OPENTitle: Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testingJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 8Issue #: 3Start Page: 249End Page: 256Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.wjorl.2021.02.001Best OA location URL: https://doi.org/10.1016/j.wjorl.2021.02.001Citation Count: 32
-
OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391001/pdf/jmcp.2021.27.6.785.pdfCitation Count: 10
-
OPENTitle: Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 12Issue #: 6Start Page: 1494End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2021.0527Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=148118Citation Count: 47
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8486338Citation Count: 26
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 54
-
OPENTitle: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 4Start Page: 596End Page: 602Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9350900Citation Count: 46
-
OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369672Citation Count: 19
-
OPENTitle: Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene HaploinsufficiencyJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 9Start Page: e2125584End Page: e2125584Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.25584Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784478/ljubenkov_2021_oi_210757_1631885845.47256.pdfCitation Count: 24
-
OPENTitle: Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2128204End Page: e2128204Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.28204Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784765/jankovic_2021_oi_210819_1632849263.95.pdfCitation Count: 34
-
OPENTitle: Effect of Urate-Elevating Inosine on Early Parkinson Disease ProgressionJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 326Issue #: 10Start Page: 926End Page: 926Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.10207Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2784144/jama_schwarzschild_2021_oi_210070_1631212847.50479.pdfCitation Count: 132